Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?

Salvatore Francesco Gervasi, Luca Pengue, Luca Damato, Riccardo Monti, Silvia Pradella, Tommaso Pirronti, Alessandro Bartoloni, Francesco Epifani, Alessio Saggese, Francesco Cuccaro, Massimiliano Bianco, Paolo Zeppilli, Vincenzo Palmieri, Salvatore Francesco Gervasi, Luca Pengue, Luca Damato, Riccardo Monti, Silvia Pradella, Tommaso Pirronti, Alessandro Bartoloni, Francesco Epifani, Alessio Saggese, Francesco Cuccaro, Massimiliano Bianco, Paolo Zeppilli, Vincenzo Palmieri

Abstract

Objective: During the COVID-19 pandemic, it is essential to understand if and how to screen SARS-CoV-2-positive athletes to safely resume training and competitions. The aim of this study is to understand which investigations are useful in a screening protocol aimed at protecting health but also avoiding inappropriate examinations.

Methods: We conducted a cohort study of a professional soccer team that is based on an extensive screening protocol for resuming training during the COVID-19 pandemic. It included personal history, antigen swabs, blood tests, spirometry, resting/stress-test ECG with oxygen saturation monitoring, echocardiogram, Holter and chest CT. We also compared the findings with prior data from the same subjects before infection and with data from SARS-CoV-2-negative players.

Results: None of the players had positive swab and/or anti-SARS-CoV-2 IgM class antibodies. Out of 30 players, 18 (60%) had IgG class antibodies. None had suffered severe SARS-CoV-2-related disease, 12 (66.7%) had complained of mild COVID-19-related symptoms and 6 (33.3%) were asymptomatic. None of the players we examined revealed significant cardiovascular abnormalities after clinical recovery. A mild reduction in spirometry parameters versus pre-COVID-19 values was observed in all athletes, but it was statistically significant (p<0.05) only in SARS-CoV-2-positive athletes. One SARS-CoV-2-positive player showed increased troponin I level, but extensive investigation did not show signs of myocardial damage.

Conclusion: In this small cohort of athletes with previous asymptomatic/mild SARS-CoV-2 infection, a comprehensive screening protocol including blood tests, spirometry, resting ECG, stress-test ECG with oxygen saturation monitoring and echocardiogram did not identify relevant anomalies. While larger studies are needed, extensive cardiorespiratory and haematological screening in athletes with asymptomatic/mild SARS-CoV-2 infection appears unnecessary.

Keywords: athlete; exercise testing; heart disease; prevention; soccer.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Instrumental findings in a player with increased troponin I level. In the only SARS-CoV-2-positive player (asymptomatic) with increased troponin I level, resting (A) and stress-test (B) ECG were normal. Chest CT at the level of the plane passing through the upper right lobar bronchus (C) and of the plane passing through lung bases (D) was absolutely normal. (E–M) Cardiac magnetic resonance images acquired using a 1.5 T Siemens Aera (Siemens Healthcare, Erlangen, Germany). (E) Short-axis cine balanced steady-state free precession showed normal left ventricle end-diastolic volume, wall thickness and motion. (F) Short-axis T2 image showed no oedema. (G, H) Short-axis and four-chamber views showed no alteration of late gadolinium enhancement. (I, J) Short-axis T1 native and T1 postcontrast maps showed normal values of T1 and extracellular volume. (K) T2 map showed no oedema.

References

    1. Phelan D, Kim JH, Chung EH. A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection. JAMA Cardiol 2020. 10.1001/jamacardio.2020.2136. [Epub ahead of print: 13 May 2020].
    1. Baggish A, Drezner JA, Kim J, et al. . Resurgence of sport in the wake of COVID-19: cardiac considerations in competitive athletes. Br J Sports Med 2020;54:1130–1. 10.1136/bjsports-2020-102516
    1. Driggin E, Madhavan MV, Bikdeli B, et al. . Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020;75:2352–71. 10.1016/j.jacc.2020.03.031
    1. Long B, Brady WJ, Koyfman A, et al. . Cardiovascular complications in COVID-19. Am J Emerg Med 2020;38:1504–7. 10.1016/j.ajem.2020.04.048
    1. Vessella T, Zorzi A, Merlo L, et al. . The Italian preparticipation evaluation programme: diagnostic yield, rate of disqualification and cost analysis. Br J Sports Med 2020;54:231–7. 10.1136/bjsports-2018-100293
    1. Narducci ML, Pelargonio G, La Rosa G, et al. . Role of extensive diagnostic workup in young athletes and nonathletes with complex ventricular arrhythmias. Heart Rhythm 2020;17:230–7. 10.1016/j.hrthm.2019.08.022
    1. Gervasi SF, Palumbo L, Cammarano M, et al. . Coronary atherosclerosis in apparently healthy master athletes discovered during pre-PARTECIPATION screening. Role of coronary CT angiography (CCTA). Int J Cardiol 2019;282:99–107. 10.1016/j.ijcard.2018.11.099
    1. Palmieri V, Gervasi S, Bianco M, et al. . Anomalous origin of coronary arteries from the "wrong" sinus in athletes: Diagnosis and management strategies. Int J Cardiol 2018;252:13–20. 10.1016/j.ijcard.2017.10.117
    1. Decree of the Italian Ministry of Health [Rules on the health protection of professional sportsmen]. Gazzetta Ufficiale della Repubblica Italiana, 1995.
    1. Sharma S, Drezner JA, Baggish A, et al. . International recommendations for electrocardiographic interpretation in athletes. Eur Heart J 2018;39:1466–80. 10.1093/eurheartj/ehw631
    1. authors V, Comitato C. Protocolli cardiologici per IL giudizio di idoneit allo sport agonistico 2017. Med Sport 2018;71:1–121.
    1. Zipes DP, Link MS, Ackerman MJ, et al. . Eligibility and Disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task force 9: arrhythmias and conduction defects: a scientific statement from the American heart association and American College of cardiology. Circulation 2015;132:e315–25. 10.1161/CIR.0000000000000245
    1. Biffi A, Delise P, Zeppilli P, et al. . Italian cardiological guidelines for sports eligibility in athletes with heart disease: Part 1. J Cardiovasc Med 2013;14:477–99. 10.2459/JCM.0b013e32835f6a21
    1. Babapoor-Farrokhran S, Gill D, Walker J, et al. . Myocardial injury and COVID-19: possible mechanisms. Life Sci 2020;253:117723. 10.1016/j.lfs.2020.117723
    1. Peretto G, Sala S, Caforio ALP. Acute myocardial injury, MINOCA, or myocarditis? improving characterization of coronavirus-associated myocardial involvement. Eur Heart J 2020;41:2124–5. 10.1093/eurheartj/ehaa396
    1. Rohleder N, Aringer M, Boentert M. Role of interleukin-6 in stress, sleep, and fatigue. Ann N Y Acad Sci 2012;1261:88–96. 10.1111/j.1749-6632.2012.06634.x
    1. Bob P, Raboch J, Maes M, et al. . Depression, traumatic stress and interleukin-6. J Affect Disord 2010;120:231–4. 10.1016/j.jad.2009.03.017
    1. Fallon KE. The clinical utility of screening of biochemical parameters in elite athletes: analysis of 100 cases. Br J Sports Med 2008;42:334–7. 10.1136/bjsm.2007.041137
    1. Banfi G, Colombini A, Lombardi G, et al. . Metabolic markers in sports medicine. Adv Clin Chem 2012;56:1–54. 10.1016/b978-0-12-394317-0.00015-7

Source: PubMed

3
Tilaa